PharmExec Direct:
Having trouble viewing this e-mail? Click here.
You are subscribed to %%list.name%% as %%emailaddr%%.
Click here to unsubscribe or edit your member profile
PharmExec Direct | From the editors of Pharmaceutical Executive Visit the PharmExec website
Send Us Some Feedback
 
December 8, 2011 | ISSUE NUMBER 229 VOL 8

Big Pharma
Lilly's Decentralized Global Launch Strategy
Global headquarters may get the strategic ball rolling for a new drug launch, but Lilly's global affiliates are responsible for bringing home the bacon, according to a Lilly global brand director ...Read More

R&D
Not Just NMEs: A New Take on R&D Decline
The hard (declining) numbers of approved NMEs in the past 10 to 15 years convey a powerful message. But is it the whole story? A new report says no ...Read More

Europe
Patient Privacy Fears Taint UK Innovation Plans
This week the UK coalition government announced some pharma-friendly plans for boosting innovation. But its decision to grant private companies access to health records was far from roundly welcomed  ...Read More

Safety
Drugmakers Seek to Outwit Generic Competitors
Erik Greb discusses how drug companies, including Pfizer, are wooing insured consumers by offering copay coupons, intended to discourage a patient from switching to a generic therapy ...Read more

// Biopharmaceutical company MediciNova (San Diego) appointed Kousuke Nakata, CPA, to its Board of Directors. // Agensys (Santa Monica, Calif.), a subsidiary of Astellas Pharma, announced that Frank P. Hudson has been appointed Vice President of Finance, and Wolfgang Noe, PhD, has been named President of Process Sciences and Manufacturing. // Alicia Grande, CPA, CMA, Corporate Controller and Chief Accounting Officer of Catalyst Pharmaceutical Partners (Coral Gables, Fla.), has been promoted to Vice President, Chief Financial Officer, and Treasurer, effective Dec. 16. // Tengion (East Norriton, Pa.) announced the appointment of John L. Miclot as its President and Chief Executive Officer. // Christopher H. Arington was promoted to Vice Chairman and Chief Executive Officer of Prasco (Cincinnati). In addition, David Vucurevich, RPh, became the company's Chief Operating Officer, David Furniss its Chief Financial Officer, and Chris Gilmore its Vice President, Strategic Business Ventures.

Dec. 9: Key Influencers and Their Networks in Hematology
San Diego, CA


Dec. 14–15: 4th Annual West Coast Life Sciences Meeting Management Forum
San Diego, CA


Feb. 16–17: Pharma Strategy and Business Innovation Conference
Cancun, Mexico


Feb. 28–29: Global Transparency Congress
London, UK



 
Follow Pharm Exec on Twitter
Follow Pharm Exec on Facebook
 


 
 
Survey
Do you support a generic-drug user fee for industry?
Click To Vote
 
Quick Links

Facebook Face Off: Merck Versus Merck

The Impact of the Ageing Population on European Healthcare

35 Years of Pharmaceutical Technology Magazine


User Management
| Subscribe | Update My Profile | Advertise With Us | Visit PharmExec.com |

You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.
To ensure delivery to your Inbox, please add us to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 1-866-529-2922 at any time, or fax us at 1-218-740-6417. Outside the U.S., please phone 1-218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.

 
Visit Pharmaceutical Executive